Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chae Moon Hong

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
The Korean Journal of Internal Medicine|March 18, 2026
High diffuse bone marrow uptake in 18F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myelomaHee Jeong Cho, Donghyeon Lee, Tan Minh Le, et al.
Scientific Reports|September 12, 2018
New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse ModelPrakash Gangadaran, Xiu Juan Li, Senthil Kumar Kalimuthu, et al.
Cancers|May 4, 2026
Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated ExosomesPrakash Gangadaran, Aswini Suresh Kumar, Kasinathan Kumaran, et al.
Cancer Cell International|August 7, 2024
Harnessing exosomes as cancer biomarkers in clinical oncologySubhrojyoti Ghosh, Ramya Lakshmi Rajendran, Atharva A Mahajan, et al.
In Vivo (Athens, Greece)|July 2, 2020
Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell LymphomaDong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2021
Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On <sup>18</sup>F-FDG PET/CT at BaselineHee Jeong Cho, Dong Won Baek, Ju-Hyung Kim, et al.
International Journal of Hematology|January 21, 2021
Prognostic impact of <sup>18</sup>F-FDG PET/CT in patients with multiple myeloma presenting with renal impairmentSeo-Yeon Ahn, Hwa Kyung Park, Joon Ho Moon, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Blood Research|February 4, 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
The Korean Journal of Internal Medicine|March 18, 2026
High diffuse bone marrow uptake in 18F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myelomaHee Jeong Cho, Donghyeon Lee, Tan Minh Le, et al.
Scientific Reports|September 12, 2018
New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse ModelPrakash Gangadaran, Xiu Juan Li, Senthil Kumar Kalimuthu, et al.
Cancers|May 4, 2026
Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated ExosomesPrakash Gangadaran, Aswini Suresh Kumar, Kasinathan Kumaran, et al.
Cancer Cell International|August 7, 2024
Harnessing exosomes as cancer biomarkers in clinical oncologySubhrojyoti Ghosh, Ramya Lakshmi Rajendran, Atharva A Mahajan, et al.
In Vivo (Athens, Greece)|July 2, 2020
Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell LymphomaDong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2021
Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On <sup>18</sup>F-FDG PET/CT at BaselineHee Jeong Cho, Dong Won Baek, Ju-Hyung Kim, et al.
International Journal of Hematology|January 21, 2021
Prognostic impact of <sup>18</sup>F-FDG PET/CT in patients with multiple myeloma presenting with renal impairmentSeo-Yeon Ahn, Hwa Kyung Park, Joon Ho Moon, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Blood Research|February 4, 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Pageof 10